ArticleMolecules (Basel, Switzerland)2022

Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer.

Amna Saeed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.